SPIRIT-Path is a project to develop International Consensus Guidance on the Inclusion of Pathology in Clinical Trial Protocols: The SPIRIT-Path Extension
The SPIRIT initiative aims to help improve the completeness and quality of trial protocols. The evidence-based SPIRIT recommendations were developed using systematic, transparent methodology and broad consultation with 115 experts representing diverse stakeholders involved in the design, funding, conduct, review, and publication of trial protocols.
CMPath has developed an extension to the SPIRIT Statement that provides specific guidance on all aspects of clinical trial pathology.
The aim of the extension to the SPIRIT statement for pathology is to:
- Lead to more comprehensive clinical trial protocols
- Enhance clinical trial design and drug development through early pathology input
- Increase the number and availability of trials-active pathologists by raising the profile of pathologists in clinical trials